Deaglan Joseph McHugh

910 total citations
37 papers, 515 citations indexed

About

Deaglan Joseph McHugh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Deaglan Joseph McHugh has authored 37 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 16 papers in Surgery. Recurrent topics in Deaglan Joseph McHugh's work include Testicular diseases and treatments (11 papers), Renal cell carcinoma treatment (8 papers) and Prostate Cancer Treatment and Research (8 papers). Deaglan Joseph McHugh is often cited by papers focused on Testicular diseases and treatments (11 papers), Renal cell carcinoma treatment (8 papers) and Prostate Cancer Treatment and Research (8 papers). Deaglan Joseph McHugh collaborates with scholars based in United States, Ireland and United Kingdom. Deaglan Joseph McHugh's co-authors include Darren R. Feldman, Michael J. Morris, Robert J. Motzer, Andrea Knežević, Chantal M. W. Tax, Mara Cercignani, Karla L. Miller, Geoff J.M. Parker, Flavio Dell’Acqua and Daniel C. Alexander and has published in prestigious journals such as Journal of Clinical Oncology, NeuroImage and Cancer.

In The Last Decade

Deaglan Joseph McHugh

33 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deaglan Joseph McHugh United States	13	262	171	146	114	107	37	515
So Won Oh South Korea	15	314 1.2×	115 0.7×	338 2.3×	76 0.7×	109 1.0×	50	732
Amelia Altavilla Italy	17	464 1.8×	146 0.9×	151 1.0×	164 1.4×	233 2.2×	44	719
Shin-ichi Yamashita Japan	15	165 0.6×	177 1.0×	41 0.3×	100 0.9×	149 1.4×	31	553
Elmar Heinrich Germany	15	328 1.3×	110 0.6×	64 0.4×	46 0.4×	138 1.3×	28	555
Kee H. Wong United Kingdom	19	218 0.8×	150 0.9×	292 2.0×	146 1.3×	127 1.2×	35	741
Joke Tio Germany	13	73 0.3×	144 0.8×	60 0.4×	167 1.5×	202 1.9×	33	571
Konrad Stawiski Poland	13	66 0.3×	235 1.4×	42 0.3×	189 1.7×	91 0.9×	47	515
Satoko Eguchi Japan	13	76 0.3×	146 0.9×	234 1.6×	73 0.6×	99 0.9×	41	705
Jae K. Lee United States	10	95 0.4×	102 0.6×	56 0.4×	105 0.9×	136 1.3×	15	418
Baixuan Xu China	12	148 0.6×	35 0.2×	216 1.5×	41 0.4×	91 0.9×	63	448

Countries citing papers authored by Deaglan Joseph McHugh

Since Specialization

Citations

This map shows the geographic impact of Deaglan Joseph McHugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deaglan Joseph McHugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deaglan Joseph McHugh more than expected).

Fields of papers citing papers by Deaglan Joseph McHugh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deaglan Joseph McHugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deaglan Joseph McHugh. The network helps show where Deaglan Joseph McHugh may publish in the future.

Co-authorship network of co-authors of Deaglan Joseph McHugh

This figure shows the co-authorship network connecting the top 25 collaborators of Deaglan Joseph McHugh. A scholar is included among the top collaborators of Deaglan Joseph McHugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deaglan Joseph McHugh. Deaglan Joseph McHugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Autio, Karen A., Deaglan Joseph McHugh, Dana E. Rathkopf, et al.. (2025). Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer. PubMed. 8(2). 172–176. 1 indexed citations

Matulewicz, Richard S., Melissa Assel, Brett S. Carver, et al.. (2025). Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors. Annals of Oncology. 36(6). 693–703. 1 indexed citations

Kotecha, Ritesh R., Andrea Knežević, Hyung Jun Woo, et al.. (2025). A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma. European Urology Oncology. 8(4). 866–870.

Fitzgerald, Kelly N., Chung‐Han Lee, Martin H. Voss, et al.. (2024). Cabozantinib Plus Nivolumab in Patients with Non–Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial. European Urology. 86(2). 90–94. 15 indexed citations

Das, Jeeban Paul, Thomas Powles, Dean F. Bajorin, et al.. (2024). Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC).. Journal of Clinical Oncology. 42(16_suppl). 4581–4581. 1 indexed citations

Knežević, Andrea, Sujata Patil, Joel Sheinfeld, et al.. (2024). Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease. Journal of Clinical Oncology. 42(26). 3130–3139. 4 indexed citations

McKay, Rana R., Lin Liu, Minya Pu, et al.. (2024). A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune).. Journal of Clinical Oncology. 42(16_suppl). TPS5128–TPS5128. 1 indexed citations

McHugh, Deaglan Joseph, et al.. (2023). Testicular cancer in 2023: Current status and recent progress. CA A Cancer Journal for Clinicians. 74(2). 167–186. 12 indexed citations

Funt, Samuel A., Andrea Knežević, Mark T.A. Donoghue, et al.. (2023). A single-arm, phase II study of durvalumab (D) and tremelimumab (T) for relapsed/refractory germ cell tumors (GCT).. Journal of Clinical Oncology. 41(16_suppl). 5040–5040. 2 indexed citations

10.

Kotecha, Ritesh R., Andrea Knežević, Joshua Chaim, et al.. (2023). A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer. European Urology Oncology. 7(4). 804–811. 11 indexed citations

11.

Lee, Chung‐Han, Kelly N. Fitzgerald, Martin H. Voss, et al.. (2023). Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial.. Journal of Clinical Oncology. 41(16_suppl). 4537–4537. 3 indexed citations

12.

Lee, Chung‐Han, Martin H. Voss, Maria I. Carlo, et al.. (2022). Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates. Journal of Clinical Oncology. 40(21). 2333–2341. 105 indexed citations

13.

Truong, Hong, Vignesh Ravichandran, Yelena Kemel, et al.. (2022). Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management.. Journal of Clinical Oncology. 40(16_suppl). 5007–5007. 1 indexed citations

14.

Kotecha, Ritesh R., Chung‐Han Lee, Deaglan Joseph McHugh, et al.. (2022). A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma.. Journal of Clinical Oncology. 40(6_suppl). 347–347. 1 indexed citations

15.

McHugh, Deaglan Joseph, Scott T. Tagawa, Natalie Moryl, et al.. (2021). A Phase II, Nonrandomized Open Trial Assessing Pain Efficacy with Radium-223 in Symptomatic Metastatic Castration-resistant Prostate Cancer. Clinical Genitourinary Cancer. 19(5). 447–456. 2 indexed citations

16.

Funt, Samuel A., Deaglan Joseph McHugh, Sang‐Bing Tsai, et al.. (2021). Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors. The Oncologist. 26(6). 483–491. 12 indexed citations

17.

McHugh, Deaglan Joseph, James C. Root, Christian J. Nelson, & Michael J. Morris. (2018). Androgen‐deprivation therapy, dementia, and cognitive dysfunction in men with prostate cancer: How much smoke and how much fire?. Cancer. 124(7). 1326–1334. 40 indexed citations

18.

Spratt, Daniel E., Deaglan Joseph McHugh, Michael J. Morris, & Alicia K. Morgans. (2018). Management of Biochemically Recurrent Prostate Cancer: Ensuring the Right Treatment of the Right Patient at the Right Time. American Society of Clinical Oncology Educational Book. 38(38). 355–362. 30 indexed citations

19.

McHugh, Deaglan Joseph, John Quinn, Patrick Thornton, et al.. (2016). Prevalence, clinico-pathological features and outcomes of ‘double-hit’ high-grade B-cell non-Hodgkins lymphoma (NHL): a single institution experience. Annals of Oncology. 27. vi315–vi315. 1 indexed citations

20.

McHugh, Deaglan Joseph, Megan Greally, Niamh M. Keegan, et al.. (2016). Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as predictive biomarkers of pathologic complete response (pCR) in neoadjuvant breast cancer: an Irish Clinical Oncology Group study (ICORG 16-20). Annals of Oncology. 27. vi532–vi532. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact